Related Experiment Video

Updated: Jun 10, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

Probing multidrug resistance P-glycoprotein transporter activity with SPECT radiopharmaceuticals

David Piwnica-Worms1, Vijay Sharma

  • 1Molecular Imaging Center, Washington University Medical School, St. Louis, MO, USA. piwnica-wormsd@mir.wustl.edu

Current Topics in Medicinal Chemistry
|July 22, 2010
PubMed

Insights

Molecular imaging probes can noninvasively visualize P-glycoprotein (Pgp) activity, aiding cancer chemotherapy and neurodegenerative disease research. This technology supports personalized medicine by stratifying patients and managing treatments effectively.

Area of Science:

  • Biomedical imaging
  • Molecular biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) via P-glycoprotein (Pgp) hinders cancer chemotherapy.
  • Pgp is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Noninvasive imaging of Pgp activity is crucial for personalized medicine.

Purpose of the Study:

  • To develop molecular imaging probes for noninvasive Pgp visualization.
  • To assess Pgp-mediated transport activity in vivo using SPECT imaging.
  • To enable personalized treatment strategies in oncology and neurology.

Main Methods:

  • Development of novel molecular imaging probes.
  • Application of Single-Photon Emission Computed Tomography (SPECT) imaging.
  • In vivo studies to evaluate Pgp transporter activity.

Main Results:

  • Demonstrated feasibility of noninvasive Pgp imaging.
  • Potential for Pgp activity assessment in tumors and brain tissues.
  • Established a tool for patient stratification and treatment monitoring.

Conclusions:

  • Molecular imaging probes offer a noninvasive method to study Pgp.
  • SPECT imaging of Pgp can guide therapeutic decisions in cancer and neurodegenerative diseases.
  • This approach supports personalized medicine and advances disease research.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment10:46

In Vivo EPR Assessment of pH, pO2, Redox Status, and Concentrations of Phosphate and Glutathione in the Tumor Microenvironment

Published on: March 16, 2018

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...